Life Sciences


1 to 10 of 858
  • Granting of gifts by pharmacies upon the purchase of price-bound prescription-only medicinal products


    Submitted: 12 September 2019

    ​The article discusses a recent judgement by the German Federal Civil Court regarding the granting of gifts in connection with the purchase of price-bound prescription-only medicinal products.

  • ICO updates guidance on DSAR response time limits

    Blog Post

    Submitted: 09 September 2019

    Data controllers will now have one month from the date of receipt of a DSAR to provide response.

  • Quarterly Asia Employment Law Update webinar


    Event date: 24 September 2019

  • Strategies for multiple SPC applications: issues highlighted by recent CJEU referrals


    Submitted: 02 September 2019

    Multiple SPC strategies based on the same product may confront issues under Article 3 of the SPC Regulation. In this article we consider how such issues arise in relation to the case in Novartis (Case 354-19) as well as multiple SPC strategies more generally.

  • The new DIFC Insolvency Law


    Submitted: 29 August 2019

    A new Dubai International Financial Centre (DIFC) Insolvency Law has been introduced incorporating new insolvency procedures and measures to facilitate improved co-operation in cross-border insolvency proceedings.

  • Parent Company Liability - When does parental control become too much?


    Submitted: 29 August 2019

    UK-headquartered multinational companies face the increased risk that non-UK claimants may be able to bring claims against them in the English courts for the overseas acts of their non-UK subsidiaries. There is an increasing trend for these claims, particularly in relation to environmental and human rights issues.

  • Mass tort case alert: Supreme Court grants permission to appeal in Shell case


    Submitted: 25 July 2019

    ​The Supreme Court has granted permission to appeal in this important mass tort case on parent company liability and jurisdiction. Chris Owen and Adam Bristow consider the impact of that decision and its interaction with the Vedanta and Unilever cases.

  • Labour Intensive - A High Impact Scenario


    Submitted: 24 July 2019

    With Boris Johnson now installed as Prime Minister, attention turns to his first 100 days and the material possibility of a Labour-led government by its end. Our latest scenario analysis shows a 70% chance of a General Election before 31 October 2019 (Johnson’s Day-99) within which a 28% chance of a Labour-Led government. In this article we have brought together the views from our specialist team of leading lawyers and financial markets experts to look in more detail at the Labour Party programme and its possible implications for all stakeholders in UK assets.

  • Non-Disclosure Agreements (NDAs) - Government response published


    Submitted: 23 July 2019

    The Government has published a response to its consultation on confidentiality clauses/NDAs (“Confidentiality clauses: measures to prevent misuse in situations of workplace harassment or discrimination”).

  • Mass torts case alert: Supreme Court refuses permission to appeal in Unilever case


    Submitted: 19 July 2019

    The Supreme Court has refused permission to appeal in this important mass tort case. Chris Owen and Adam Bristow consider the impact of that decision and how it contrasts with the recent Supreme Court judgment in Vedanta.

1 to 10 of 858